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Advances in infectious disease modeling may offer opportunities to mitigate the effect of emerging infectious 
diseases upon military readiness (1–3). In August 2005, the US Department of Defense (DoD) Global 
Emerging Infections Surveillance and Response System (GEIS) sponsored a meeting on the epidemiologic 
applications of infectious disease modeling in support of DoD readiness. Several recommendations were 
made at this conference to include the identification of organizations with "…demonstrated expertise in 
model development and operation for collaboration with the DoD and civilian organizations that are 
developing simulation models or conducting exercises" (4). Despite this recommendation, infectious disease 
modeling efforts in support of DoD have remained somewhat disjointed. An infectious disease modeling 
collaboration between DoD-GEIS and The Johns Hopkins Applied Physics Laboratory, begun in 2007, again 
identified this issue. Concerned that opportunities for collaboration might be missed and that unintended 
redundancy might be occurring, DoD-GEIS sponsored a second conference on May 12–13, 2008, for 
infectious disease modelers engaged in DoD projects or on models useful to the DoD. 
Over 30 participants from 10 agencies met for a day and a half at the Infectious Disease Modeling Meeting 
on the campus of the Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA 
(Appendix). The first day consisted of presentations detailing past and current work by the participating 
organizations. These presentations are available on the secure DoD-GEIS website for governmental 
organizations, collaborators, and academic institutions (request access from 
http://www.AFHSC.mil/about_GEIS.asp). The second day consisted of a roundtable discussion of how to 
optimize DoD-relevant infectious disease modeling efforts; specifically, how to maximize opportunities for 
collaboration and coordination while minimizing unintended redundancy. 
The roundtable discussion first turned to who was at the table, and importantly, who was not. Many 
participants had also attended the 2005 conference, although some had not, and some of the key attendees 
at the 2005 conference were not present for the 2008 meeting. A strong recommendation was again made 
to identify all key organizations involved in infectious disease modeling of use to DoD. Additionally, because 
of the blurred lines of responsibility among federal agencies, participants thought that many other non-DoD 
federal organizations should participate in these types of discussions. Some participants called for the 
creation of a formal organization or society of infectious disease modelers. The Models of Infectious Disease 
Agent Study (MIDAS; http://www.nigms.nih.gov/Initiatives/MIDAS/Background/Factsheet.htm) group was 
mentioned as already serving as a nexus for the modeling community, but the need for a larger, coordinating 
body was expressed. Representatives from the Armed Forces Health Surveillance Center (the parent 
organization of DoD-GEIS; http://afhsc.army.mil/About_AFHSC.asp) indicated a willingness to be involved in 
future efforts in a coordinating capacity. 
Participants also addressed the ambiguity associated with the term modeling, even within the infectious 
disease modeling community. Models may be used to provide indicators or warnings, surveillance data, or 
casualty prediction or to assist with consequence management, resource allocation, or policy development. 
Many models provide various combinations of these functions. Some participants believed it was important 
to organize modeling efforts by the functionality of the models in question. A stimulating discussion centered on who should have access to infectious disease models. Some thought that models should remain only in 
the hands of the experts who create them and can manage and interpret them. Others believed that state 
and community officials, who presumably have much greater local knowledge but less mathematical 
acumen, should be allowed access to the models. 
The conference ended by reiterating the recommendation that the entire community of those working on 
disease modeling of interest to DoD should not only be identified but also strongly encouraged to meet again 
within the year. In addition to sharing ideas and work, participants of the 2008 conference recommended the 
development of a format and plan for ongoing communication and collaboration. This plan could include the 
formation of productive work groups to address definitions, e.g., the meaning of modeling, and to develop 
recommendations on the use of infectious disease models. The creation of a professional society for federal 
disease modelers could facilitate these actions and was identified for serious consideration. 
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Affiliations of conference participants at the Infectious Disease Modeling Meeting held May 12–13, 2008, at 
the Johns Hopkins University Applied Physics Laboratory: 
Armed Forces Health Surveillance Center, US Department of Defense, Silver Spring, Maryland, USA 
Defense Threat Reduction Agency, US Department of Defense, Alexandria, Virginia, USA 
Global Emerging Infections Surveillance and Response System, US Department of Defense, Silver Spring, 
Maryland, USA 
Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA 
Quantum Leap Innovations, Inc., Arlington, Virginia, USA 
Sandia National Laboratories, Albuquerque, New Mexico, USA 
Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA 
US Department of Health and Human Services, Washington, DC, USA US Department of Veterans Affairs, Washington, DC, USA 
Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA 
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